Hepatitis Vaccine Market – Analysis, Opportunities and Trends in the Global Industry, 2022-2028

 

Hepatitis Vaccine

Hepatitis is an infectious condition brought on by the hepatitis virus types A, B, and C. These viruses are responsible for disorders related to the liver, including cirrhosis of the liver, hepatocellular carcinoma, and liver failure. A person who is infected could die from it. The hepatitis A and hepatitis B viruses are spread by contact with bodily fluids of those who have the infection (blood, for example). Both hepatitis A and hepatitis B can be prevented with hepatitis vaccines, boosting immunity and preventing complications including cancer and liver failure. The most susceptible group to infection is children. In the world, hepatitis B is more prevalent than hepatitis A.

One of the most prevalent infectious diseases in the world, hepatitis has caught the attention of medical organisations like the World Health Organization due to its seriousness (WHO).

The Hepatitis Vaccine Market is anticipated to grow as a result of the increased prevalence of hepatitis around the world. The rising global population is a further element driving the Hepatitis Vaccine Market expansion (live births). By 2025, the population of the globe will increase to 9 billion people thanks to more live births each year, predicts the 2017 World Population Report. In order to protect newborns from hepatitis B infection, the WHO recommends that hepatitis B immunisation be given within the first 24 hours of delivery. Additionally, increasing public understanding of the benefits of hepatitis immunisation would help the hepatitis vaccine industry develop its market. The global market for hepatitis vaccines will grow as a result of the numerous companies releasing vaccines to prevent hepatitis A and B.

An increase in public awareness about Hepatitis Infection prevention. Moreover, various governments worldwide are introducing hepatitis vaccination programmes.

On the basis of Indication

·       Hepatitis A

·       Hepatitis B

On the basis of Vaccine Type

·       Recombinant Vaccine

·       Inactivated Vaccine

On the basis of Distribution Channel

·       Hospitals

·       Retail Pharmacy

·       Online Pharmacy

Top Companies involved are- Merck and Company, GlaxoSmithKline, Sanofi Pasture, CSL Behring GmbH, Novartis AG and Pfizer Inc. Few leading brands in hepatitis vaccine market are Engerix-B, Havrix (Glaxosmithkline), Recombivax, Vaqta (Merck and Company), Euvax – Avaxim (Sanofi Pasteur), and Shanvac B (Shantha Biotech)

Comments

Popular posts from this blog

Electric Wheelchair Market Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028

The Global Benzocaine Market Size Is Expected To Exhibit A Cagr Of 2.70% Over The Forecast Period (2020-2027).

Ginseng Market Outlook, Analysis and forecast up to 2028